Literature DB >> 24421535

Cannabinoid hyperemesis syndrome.

Shusen Sun1, Anthony E Zimmermann2.   

Abstract

BACKGROUND: The purpose of this review is to describe cannabinoid hyperemesis syndrome (CHS), which is thought to be induced by long-term cannabis use, and provide clinical pharmacists with information to manage the hyperemetic phase of CHS.
METHOD: Published literature was searched and reviewed using PubMed.
RESULTS: CHS is characterized by intractable nausea and vomiting without an obvious organic cause and associated learned compulsive hot water bathing behavior. Patients often seek care in the emergency department (ED) for symptomatic relief.
CONCLUSION: CHS is potentially underrecognized and underdiagnosed in the ED, and it should be considered in the differential diagnosis in long-term cannabis use patients with CHS symptoms to avoid unnecessary extensive diagnostic workup including invasive radiologic imaging. Pharmacists have an important role in CHS recognition, education, and symptom management.

Entities:  

Keywords:  cannabinoid hyperemesis syndrome; chronic cannabis use; clinical pharmacists; compulsive hot water bathing; intractable nausea and vomiting

Year:  2013        PMID: 24421535      PMCID: PMC3847982          DOI: 10.1310/hpj4808-650

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  20 in total

1.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003.

Authors:  Louisa Degenhardt; Wai Tat Chiu; Nancy Sampson; Ronald C Kessler; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2007-05-03       Impact factor: 4.492

Review 3.  Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.

Authors:  Erik A Wallace; Sarah E Andrews; Chad L Garmany; Martina J Jelley
Journal:  South Med J       Date:  2011-09       Impact factor: 0.954

4.  Waning effect of compulsive bathing in cannabinoid hyperemesis.

Authors:  Satish Bagdure; Roger D Smalligan; Houman Sharifi; Bharat Khandheria
Journal:  Am J Addict       Date:  2012-02-07

5.  Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects.

Authors:  J Laszlo; R A Clark; D C Hanson; L Tyson; L Crumpler; R Gralla
Journal:  J Clin Oncol       Date:  1985-06       Impact factor: 44.544

6.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

7.  Cannabinoid hyperemesis: marijuana puts patients in hot water.

Authors:  Duncan Wallace; Ana-Louise Martin; Bianca Park
Journal:  Australas Psychiatry       Date:  2007-04       Impact factor: 1.369

8.  Cannabinoid hyperemesis relieved by compulsive bathing.

Authors:  Yoon Hee Chang; Donna M Windish
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

Review 9.  Cyclic vomiting syndrome: what a gastroenterologist needs to know.

Authors:  Namita Pareek; David R Fleisher; Thomas Abell
Journal:  Am J Gastroenterol       Date:  2007-12       Impact factor: 10.864

10.  Medical marijuana: clearing away the smoke.

Authors:  Igor Grant; J Hampton Atkinson; Ben Gouaux; Barth Wilsey
Journal:  Open Neurol J       Date:  2012-05-04
View more
  11 in total

1.  Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review.

Authors:  Justin P Reinert; O'Neill Niyamugabo; Kiersi S Harmon; Norman E Fenn
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

2.  Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury.

Authors:  Priya Srihari; Mengyang Liu; Steven Punzell; Shady S Shebak; William S Rea
Journal:  Prim Care Companion CNS Disord       Date:  2016-02-25

3.  In Response to: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Joanne C Routsolias
Journal:  J Med Toxicol       Date:  2017-03-09

Review 4.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

5.  Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.

Authors:  Andrea Bollom; Jasmine Austrie; William Hirsch; Judy Nee; Daniel Friedlander; Johanna Iturrino; Sarah Ballou; Anthony Lembo
Journal:  J Clin Gastroenterol       Date:  2018-10       Impact factor: 3.062

Review 6.  Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

Authors:  Katherine A Belendiuk; Lisa L Baldini; Marcel O Bonn-Miller
Journal:  Addict Sci Clin Pract       Date:  2015-04-21

Review 7.  Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment.

Authors:  Christian G Blumentrath; Boris Dohrmann; Nils Ewald
Journal:  Ger Med Sci       Date:  2017-03-21

8.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

Authors:  Thangam Venkatesan; David J Levinthal; B U K Li; Sally E Tarbell; Kathleen A Adams; Robert M Issenman; Irene Sarosiek; Safwan S Jaradeh; Ravi N Sharaf; Shahnaz Sultan; Christopher D Stave; Andrew A Monte; William L Hasler
Journal:  Neurogastroenterol Motil       Date:  2019-06       Impact factor: 3.598

9.  Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition.

Authors:  João Machado Nogueira; Inês Fonseca; Marco Duarte
Journal:  GE Port J Gastroenterol       Date:  2020-12-30

Review 10.  Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.

Authors:  Krzysztof Laudanski; Justin Wain
Journal:  J Clin Med       Date:  2022-01-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.